Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography

Table 2 Final diagnosis n (%)

	Non-stent	Stent	P value
Biliary disease
CBD stone	16 (27)	15 (25)	0.68
Cholangitis	2 (3)	2 (3)	0.49
Cholangiocarcinoma	4 (7)	3 (5)	1
Cholangiocellular carcinoma	2 (3)	1 (2)	1
Benign biliary stricture	1 (2)	2 (3)	1
Primary sclerosing cholangitis	2 (3)	1 (2)	1
GB stone	1 (2)	0 (0)	1
GB polyp	1 (2)	1 (2)	1
GB adenomyomatosis	1 (2)	1 (2)	0.46
Cholecystitis	1 (2)	1 (2)	0.46
GB carcinoma	3 (5)	3 (5)	0.47
Pancreatic disease
IPMN	10 (17)	11 (18)	0.67
MCN	0 (0)	1 (2)	1
SCN	1 (2)	0 (0)	1
Chronic pancreatitis	3 (5)	3 (5)	0.47
Pancreatic cyst	1 (2)	2 (3)	1
Pancreatic carcinoma	11 (18)	13 (22)	0.65

CBD: Common bile duct; GB: Gallbladder; IPMN: Intraductal papillary mucinous neoplasm; MCN: Mucinous cystic neoplasm; SCN: Serous cystic neoplasm.